4//SEC Filing
NEWLINK GENETICS CORP 4
Accession 0001126234-16-000237
CIK 0001126234operating
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 5:53 PM ET
Size
9.8 KB
Accession
0001126234-16-000237
Insider Transaction Report
Form 4
NEWLINK GENETICS CORP(NLNK)
Link Charles J. Jr.
DirectorChairman of the Board & CEO
Transactions
- Sale
Common Stock
2016-03-15$18.60/sh−5,000$93,000→ 292,756 total - Sale
Common Stock
2016-03-15$17.68/sh−20,000$353,600→ 297,756 total
Holdings
- 25,000(indirect: By Spouse)
Common Stock
- 139(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on 5/26/2015, as amended 1/28/2016.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.30 to $18.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote to this Form 4.
- [F3]Includes 11,500 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on January 2, 2017, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F4]Includes 33,750 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on January 2, 2017, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F5]Includes 46,639 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments with the next installment occurring on January 4, 2017, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
Documents
Issuer
NEWLINK GENETICS CORP
CIK 0001126234
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001126234
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 5:53 PM ET
- Size
- 9.8 KB